Cancer: Drug for an 'undruggable' protein

Nature

Volumn 497, Issue 7451, 2013, Pages 577-578

  Baker, Nicole M ^a   Der, Channing J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DELTARASIN; K RAS PROTEIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

CELLULAR DISTRIBUTION; NOTE; ONCOGENE N RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

ANIMALS; BENZIMIDAZOLES; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 6; HUMANS; ONCOGENE PROTEIN P21(RAS); SIGNAL TRANSDUCTION;

EID: 84878411511     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature12248     Document Type: Note

References (10)

1. Cox, A. D. & Der, C. J. Small GTPases 1, 2-27 (2010).
2. Zimmermann, G. et al. Nature 497, 638-642 (2013).
3. Berndt, N., Hamilton, A. D. & Sebti, S. M. Nature Rev. Cancer 11, 775-791 (2011).
4. Ahearn, I. M., Haigis, K., Bar-Sagi, D. & Philips, M. R. Nature Rev. Mol. Cell Biol. 13, 39-51 (2012).
5. Philips, M. R. Nature Cell Biol. 14, 128-129 (2012).
6. Nancy, V., Callebaut, I., El Marjou, A. & de Gunzburg, J. J. Biol. Chem. 277, 15076-15084 (2002).
7. Ismail, S. A. et al. Nature Chem. Biol. 7, 942-949 (2011).
8. Chandra, A. et al. Nature Cell Biol. 14, 148-158 (2012).
9. Zhang, H. et al. Proc. Natl Acad. Sci. USA 104, 8857-8862 (2007).
10. Laheru, D. et al. Invest. New Drugs 30, 2391-2399 (2012).